The QIAstat-Dx Viral Vesicular Panel is currently for research use only, Qiagen said Aug. 15. It tests for the two known forms of monkeypox, and differentiates them from herpes simplex virus 1 and 2, human herpesvirus 6, varicella-zoster virus and enterovirus, which all produce similar lesions.
The test can be used for monkeypox case surveillance, but is not approved for screening or diagnosing.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
